PUVIDA WART REMOVAL SYSTEM- salicylic acid 17% wart removal system liquid

PUVIDA Wart Removal System by

Drug Labeling and Warnings

PUVIDA Wart Removal System by is a Otc medication manufactured, distributed, or labeled by Jiangxi Hemei Pharmaceutical Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient

Salicylic acid 17%

Purpose

Wart remover

Use

For the removal of common warts and plantar warts.Common warts have a rough"cauliflower-like" surface and are easily recognizable.Plantar warts are located only on the soles of the feet, tender to touch, with an interrupted footprint pattern.

Warnings

For external use only.

Do not use

on irritated skin or on any area that is infected or reddened·On moles, birthmarks, warts with hair growing from them, genital warts or
warts on the face or mucous membranes If you have diabetes or poor blood circulation.


.

When Using

Avoid contact with eyes. lf product gets into the eye, flush with Water for 15 minutes.Non-edible. Cap tightly and store at room temperature, away from heat.

Stop Use

Stop use and ask a doctor if discomfort persists.

Ask Doctor

Stop use and ask a doctor if discomfort persists.

Keep Oot Of Reach Of Children

If swallowed, get medical help or contact the Poison Control Center (1-800-222-1222) right away.

Directions

Wash the affected area.May soak wart in warm water for 5 minutes. Dry area thoroughly.
Use a cotton swab to apply a sufficient amount to cover each wart. Let it dry.Repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks.

Other information

Store at room temperature.Avoid excessive heat (37°C/ 99°F).Skin discoloration may occur during or after use.

Inactive ingredients

Water，Polyethylene Glycol，Glycerin，Borneol.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

PUVIDA WART REMOVAL SYSTEM 
salicylic acid 17% wart removal system liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84010-210
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	17 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
GLYCERIN (UNII: PDC6A3C0OX)
BORNEOL (UNII: M89NIB437X)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84010-210-01	4 mL in 1 TUBE; Type 0: Not a Combination Product	10/30/2025
2	NDC: 84010-210-02	2.5 mL in 1 TUBE; Type 0: Not a Combination Product	10/30/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M028	10/30/2025

Labeler - Jiangxi Hemei Pharmaceutical Co., Ltd (724892056)

Establishment
Name	Address	ID/FEI	Business Operations
Jiangxi Hemei Pharmaceutical Co., Ltd		724892056	manufacture(84010-210)